Clinical Trials Logo

Cognitive Decline clinical trials

View clinical trials related to Cognitive Decline.

Filter by:

NCT ID: NCT03860857 Recruiting - Alzheimer Disease Clinical Trials

Biomarker Exploration in Aging, Cognition and Neurodegeneration

BEACoN
Start date: May 1, 2018
Phase: Phase 3
Study type: Interventional

The purpose of this research study is to understand the factors that underlie changes in thinking and memory with increasing age. The investigators will test the usefulness of MRI, PET, and cognitive testing in detecting subtle changes in the brain that precede cognitive decline. An addendum to this study includes additional PET scans to examine the relationship between tau protein in the brain and cognitive decline. Tau is a protein that is known to form tangles in the areas of the brain important for memory, and these tau tangles are a hallmark of Alzheimer's disease. This sub-study research aims to look at the tau accumulation in the brain using an investigational drug called MK-6240, which is a radio tracer that gets injected prior to a positron emission tomography (PET) scan.

NCT ID: NCT03839784 Recruiting - Clinical trials for Cognitive Impairment

Building a Platform for Precision Anesthesia in the Geriatric Surgical Patient

Start date: September 1, 2020
Phase:
Study type: Observational [Patient Registry]

The research team is creating a foundational infrastructure in order to develop a precision medicine approach for geriatric patients who require surgery with anesthesia. The team plans to build the first of its kind comprehensive database of demographic and risk factor questionnaire responses, biobanked blood specimens, intraoperative electroencephalography (EEG), and inclusive cognitive testing throughout patient interaction starting at the preop appointment until a year later. This will be used to create a predictive model of periooperative neurocognitive disorders.

NCT ID: NCT03804658 Recruiting - Cognitive Decline Clinical Trials

The Factors Affecting the Achievement of Glucose Monitor in the Patients on Diabetes

Start date: January 13, 2019
Phase:
Study type: Observational [Patient Registry]

To assess the effect of glucose monitors on glucose control and cardiovascular risks.

NCT ID: NCT03794427 Recruiting - Cognitive Decline Clinical Trials

Combined Lumbosacral Nerve Block Versus Spinal Anesthesia for Cognitive Function After Hip Prothesis

Start date: January 2, 2019
Phase: N/A
Study type: Interventional

Hip fracture is a potentially devastating event, and serious surgical and medical complications occur frequently especially for elderly patients. Delirium is one of the common complications after hip surgery. Controversy exists regarding the possible impact of type of anesthesia (nerve block versus spinal) upon acute and long-term cognitive decline. The primary objective is to assess the association between type of anesthesia (nerve block vs. spinal anesthesia) and risk of cognitive decline (CD). The secondary objective is to compare intra-operative hemodynamic changes, use of vasopressor drugs, and use of post-operative analgesics with respect to the type of anesthesia. Prospective, double blind randomized clinical trial of hip fracture patients who will be assessed for CD pre- and postoperatively, using the Mini Mental State Examination (MMSE). The presence of CD will be determined at follow-up evaluation up to three months after surgery.

NCT ID: NCT03765840 Recruiting - Cognitive Decline Clinical Trials

Study of Postoperative Cognitive Decline in Aged Patients

Start date: May 1, 2018
Phase:
Study type: Observational

postoperative cognitive decline is a common and deleterious complication in aged patients.The link between inflammation and postoperative cognitive decline has also been reported.However,the link between SOD1,SOD2,Osteopontin, Kallikrein-6,and Contactin-1 and postoperative cognitive decline is unknown. In this project ,investigators examine the relationship between 5 cytokines measured at there timepoints (preoperative [PREOP], postoperative day 1 [POD1] , and postoperative day 3[POD2]) and postoperative cognitive decline among older adults undergoing orthopedic surgery.

NCT ID: NCT03657745 Recruiting - Alzheimer Disease Clinical Trials

Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy

AlzLife
Start date: January 1, 2018
Phase:
Study type: Observational

Electrical activity in the brain known as "gamma" brainwaves help connect and process information throughout the brain. These gamma waves are diminished in Alzheimer's disease. New research in Alzheimer's disease mouse models shows that exposure to light flickering at the rate of 40 flashes per second or 40Hz increased gamma brainwaves and led to clearing of beta amyloid plaques in the brain, a key abnormality in Alzheimer's disease. This project will test the ability of a novel iPad App (AlzLife https://www.alz.life/) that delivers light therapy at 40 Hz combined with cognitive therapy to improve cognition, function, and quality of life in Alzheimer's disease.

NCT ID: NCT03451383 Recruiting - Cognitive Decline Clinical Trials

Older Breast Cancer Patients: Risk for Cognitive Decline

TLC
Start date: August 1, 2010
Phase:
Study type: Observational

The goal of this study is to evaluate the impact of systemic therapy on cognition in older breast cancer patients, explore change in APE, LM and Cognition domains, measure associations between cognitive decline and QOL, and describe how genetic polymorphisms, inflammatory biomarkers, sleep and physical measures moderate cognitive outcomes. This study is being done nationally, with recruiting sites at Georgetown University, Montgomery General Hospital, Virginia Cancer Specialists, Washington Hospital Center, Reston Breast Care Specialists, Memorial Sloan-Kettering, Moffitt Cancer Center, City of Hope National Medical Center, Hackensack University Medical Center, Indiana University and University of California, Los Angeles.

NCT ID: NCT03410173 Recruiting - Diabetes Mellitus Clinical Trials

Taurine Supplementation on Cognitive Function in Patients With Diabetes

Start date: January 2017
Phase: N/A
Study type: Interventional

Diabetes has become important risk factors for threatening human life and health. Studies have shown that chronic hyperglycemia lead to microvascular brain injury. The more common types of dementia are Alzheimer's disease (AD). Cognitive dysfunction is a precursor to Alzheimer's disease. Mild cognitive impairment (MCI) is a cognitive impairment between normal aging and dementia, mainly manifested as memory impairment, especially episode memory defects, but also named obstacles, but the overall cognitive function is normal, daily life ability is normal. Studies have shown that middle-aged diabetic patients' cognitive ability will decline by about 19% in 20 years compared to people without diabetes. Sulfur amino acid is the indispensable amino acid in mammals, and its metabolites include Taurine, Hydrogen sulfide (H2S) and sulfur dioxide (SO2). Taurine was first isolated more than 150 years ago from ox (Taurus) bile. Although the taurine can be synthesized in vivo by cysteine in the presence of cysteine dioxygenase, it is mainly acquired from dietary sources, such as eggs, meat, and seafood. H2S is a biologically relevant mediator and plays potential roles in several physiological processes and disease states in the body. H2S is synthesized from 2 sulfur-containing amino acids, l-cysteine andl-methionine, by the 3 enzymes,cystathionine-γ-lyase (CSE), cystathionine-β-synthetase(CBS), and3-mercaptopyruvate sulfurtransferase (3-MST). Previous studies have demonstrated that Taurine and H2S may play important roles in the development of themicroangiopathy and lower extremity arterial occlusive.

NCT ID: NCT03360838 Recruiting - Clinical trials for Cognitive Impairment

Development of a Prediction Model for Delirium After Cardiac Surgery Using a Novel Self-Administered Preoperative Cognitive Assessment Tool

CogCheck-Valid
Start date: April 16, 2018
Phase:
Study type: Observational

This observational cohort study is designed to validate the CogCheck application as a risk prediction tool for postoperative delirium in patients undergoing cardiac surgery.

NCT ID: NCT03356769 Recruiting - Epilepsy Clinical Trials

Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex

Start date: November 20, 2017
Phase: Phase 2
Study type: Interventional

There had been much evidence in aspirin controlling tumorous conditions conducted by basic researches, especially through mammilian target of rapamycin (mTOR) pathway. The investigator observed efficacy of aspirin in the treatment of tuberous sclerosis complex (TSC) in one child who got Kawasaki disease and in the addition four TSC patients with epilepsy. The investigator intend to evaluate whether aspirin would be an effective add-on treatment in TSC patients with refractory seizures.